Skip to main navigation Skip to search Skip to main content

Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis

  • Mohamed Elgendy
  • , Marco Cirò
  • , Amir Hosseini
  • , Jakob Weiszmann
  • , Luca Mazzarella
  • , Elisa Ferrari
  • , Riccardo Cazzoli
  • , Giuseppe Curigliano
  • , Andrea DeCensi
  • , Bernardo Bonanni
  • , Alfredo Budillon
  • , Pier Giuseppe Pelicci
  • , Veerle Janssens
  • , Manfred Ogris
  • , Manuela Baccarini
  • , Luisa Lanfrancone
  • , Wolfram Weckwerth
  • , Marco Foiani
  • , Saverio Minucci

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)798-815.e5
Number of pages23
JournalCancer Cell
Volume35
Issue number5
DOIs
Publication statusPublished - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Austrian Fields of Science 2012

  • 301206 Pharmacology

Keywords

  • metformin
  • glucose
  • hypoglycemia
  • fasting
  • caloric restriction
  • MCL-1
  • GSK3ß
  • PP2A
  • metabolic plasticity
  • tumor metabolism
  • APOPTOSIS
  • SUPPRESSOR
  • ACTIVATION
  • KINASE
  • BREAST-CANCER PROLIFERATION
  • RESTRICTION
  • RESISTANCE
  • DEGRADATION
  • TUMORIGENESIS
  • MCL1

Fingerprint

Dive into the research topics of 'Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis'. Together they form a unique fingerprint.

Cite this